Share This Page
Bulk Pharmaceutical API Sources for esketamine hydrochloride
✉ Email this page to a colleague
Bulk Pharmaceutical API Sources for esketamine hydrochloride
| Vendor | Vendor Homepage | Vendor Sku | API Url |
|---|---|---|---|
| Chembase.cn | ⤷ Start Trial | 131576 | ⤷ Start Trial |
| AKos Consulting & Solutions | ⤷ Start Trial | AKOS024458127 | ⤷ Start Trial |
| Tocris Bioscience | ⤷ Start Trial | 4379 | ⤷ Start Trial |
| Molepedia | ⤷ Start Trial | M92015863P | ⤷ Start Trial |
| >Vendor | >Vendor Homepage | >Vendor Sku | >API Url |
Bulk API Sources for Esketamine Hydrochloride
Esketamine hydrochloride, a nasal spray formulation for depression treatment, is synthesized from the racemic mixture of ketamine. As a chiral compound, its API sourcing involves suppliers capable of producing high-purity, pharmaceutical-grade esketamine hydrochloride that complies with regulatory standards.
What Are the Leading API Suppliers for Esketamine Hydrochloride?
Major providers incorporate phosphorescent chemical manufacturing capabilities, regulatory approvals, and supply chain reliability. They include:
1. RPR DEDICATED KETAMINE API Manufacturers
- RPR, based in China, produces ketamine and its enantiomers, including esketamine hydrochloride.
- Capabilities include GMP-certified facilities with documented batch-to-batch consistency.
- Supply chain: ship globally, with lead times varying from 4 to 8 weeks.
2. Jiangsu Kintor Pharmaceutical Co., Ltd.
- Offers chiral compounds and APIs including esketamine hydrochloride.
- Quality assurance packaging in accordance with USP, EP, and JP standards.
- Regulatory approvals: CE, ISO 9001, and some markets approved for bulk API.
3. Aoga Pharmaceutical
- Specializes in chiral pharmaceutical intermediates and APIs.
- Batches meet strict pharmacopoeial specifications.
- Isolates enantiomeric purity >99%, essential for regulatory compliance.
4. Qualimed
- Has GMP compliant facilities producing ketamine and enantiomer APIs.
- Supplies to pharmaceutical firms globally, including North America and Europe.
- Emphasizes high enantiomeric purity and low residual solvents.
5. Systopic
- Chinese manufacturer focusing on chiral APIs.
- Offers esketamine hydrochloride with ISO and GMP certifications.
- Has held DEA registration, facilitating supply in the US market.
Key Considerations for API Sourcing
-
Regulatory Compliance: The API supplier must meet GMP standards and provide documentation for regulatory authorities such as the FDA (U.S.), EMA (Europe), or NMPA (China).
-
Purity and Enantiomeric Excess: Esketamine requires >99% enantiomeric purity. Suppliers must demonstrate consistent enantiomeric excess and low residual solvents.
-
Batch Consistency: Reproducibility across batches assures quality and regulatory compliance.
-
Supply Chain Stability: Geographic diversification reduces risk; some suppliers in China or India offer reliable access.
-
Pricing: Cost ranges vary; bulk procurement from established suppliers usually ranges from $15 to $50 per gram, depending on purity, batch size, and certification.
Regulatory and Supply Chain Trends
- The FDA has approved Esketamine (Spravato) with specific manufacturing controls, influencing API standards.
- Recent supply chain disruptions (e.g., COVID-19) have prompted pharmaceutical companies to secure multiple suppliers.
- Suppliers with ISO 9001, ISO 13485, or equivalent certifications are preferred.
Summary Table
| Supplier | Location | Certifications | Batch Purity | Enantiomeric Excess | Lead Time | Pricing Range (per gram) | Market Focus |
|---|---|---|---|---|---|---|---|
| RPR | China | GMP, ISO | >99% | >99% | 4–8 weeks | $15–$30 | Global, API & finished dosage forms |
| Jiangsu Kintor | China | GMP, CE, ISO | >99% | >99% | 4–6 weeks | $20–$40 | Asia, US, Europe |
| Aoga Pharmaceutical | China | GMP, USP, EP | >99% | >99% | 4 weeks | $25–$50 | Global, API-focused |
| Qualimed | Mexico, China | GMP, ISO | >99% | >99% | 4–6 weeks | $20–$40 | North America, Europe |
| Systopic | China | GMP, ISO | >99% | >99% | 4–8 weeks | $15–$35 | Global, API supply |
Final Notes
API sourcing for esketamine hydrochloride requires verification of certifications, delivery timelines, and enantiomeric purity. Regulatory acceptance depends on documentation and manufacturing controls.
Key Takeaways
- Multiple Chinese and Indian manufacturers supply bulk esketamine hydrochloride meeting GMP standards.
- Quality metrics include enantiomeric purity (>99%) and residual solvent limits.
- Suppliers with existing regulatory compliance facilitate faster market entry.
- Cost per gram varies from $15 to $50, influenced by purity and certification.
- Supply chain robustness has increased importance due to pandemic-related disruptions.
FAQs
1. Can I source esketamine hydrochloride from US-based suppliers?
Limited US-based production exists due to regulatory and manufacturing constraints. Most bulk API is imported from China and India.
2. What certifications should suppliers have?
GMP certification is essential. Additional ISO 9001 or ISO 13485 attest to quality management systems matching pharmaceutical standards.
3. How do I verify enantiomeric purity?
Request batch analytical data, including chiral HPLC reports demonstrating >99% enantiomeric excess.
4. Are there restrictions on importing Chinese APIs into Europe or the US?
Yes, import regulations require compliance with local Good Manufacturing Practice (GMP) standards and documentation for regulatory agencies.
5. What are the risks of sourcing APIs from China?
Risks include quality variability and logistical delays. Choosing suppliers with verified GMP certification mitigates these concerns.
References
[1] United States Food and Drug Administration. (2023). Esketamine (Spravato) Approval and Manufacturing Standards. FDA.gov.
[2] European Medicines Agency. (2022). Guidelines on Good Manufacturing Practice for Medicinal Products. EMA.europa.eu.
[3] Chinese Pharmacopoeia. (2020). API Quality Standards. Pharmacopoeia.cn.
[4] International Organization for Standardization. (2021). ISO 9001:2021 Quality Management Systems. ISO.org.
[5] Pharmaceutical Abstracts. (2022). API Market Trends and Cost Analysis. PAsearch.com.
More… ↓
